Kimberly-Clark Corporation reported third quarter 2026 net sales of $4.1 billion, down 0.4 percent year-over-year, alongside a 1.3 percent decline in organic sales driven by headwinds in China and North American inventory movements. Diluted earnings per share from continuing operations were $1.19, while adjusted EPS rose 17.2 percent to $1.70. Additionally, the company completed its Kenvue acquisition and the International Family Care and Professional transaction.
Delivered third quarter net sales of $4.1 billion, representing a 0.4 percent decrease compared to the prior year.
Reported third quarter diluted EPS from continuing operations of $1.19, and adjusted EPS of $1.70.
Completed the Kenvue transaction and the International Family Care and Professional transaction during the quarter.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Kimberly-Clark's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$16.45B
-2.1%
$6.07
-19.6%
12.3%
FY2024
$16.80B
-2.0%
$7.55
+44.9%
15.1%
FY2023
$17.15B
+1.1%
$5.21
-8.9%
10.3%
FY2022
$16.95B
-12.8%
$5.72
+6.9%
11.4%
FY2021
$19.44B
+1.6%
$5.35
-22.1%
9.3%
Frequently asked questions
When is Kimberly-Clark's next earnings date?
Kimberly-Clark has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Kimberly-Clark earn last quarter?
For the quarter ended Sep 2026, Kimberly-Clark reported diluted EPS of $5.37 (+300.7% year over year) on revenue of $4.13B (-0.4%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.